vimarsana.com
Home
Live Updates
Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights : vimarsana.com
Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights : vimarsana.com
Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
WATERTOWN, Mass., March 28, 2024 -- Acrivon Therapeutics, Inc. , a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are...
Related Keywords
United States ,
San Diego ,
California ,
Sweden ,
American ,
Peter Blume Jensen ,
Santhosh Palani ,
Ivana Magov ,
Alexandra Santos ,
Jean Marie Cuillerot ,
Exchange Commission ,
Acrivon Therapeutics Inc ,
Health Sciences ,
Drug Administration ,
American Association For Cancer Research ,
Vigil Neuroscience Inc ,
Acrivon Predictive Precision Proteomics ,
American Association ,
Cancer Research ,
Annual Meeting ,
Wall Street ,
Vigil Neuroscience ,
Full Year ,
Fast Track ,
Breakthrough Device ,
Private Securities Litigation Reform Act ,
Media Contacts ,
Comprehensive Loss ,
Months Ended ,
Ended December ,
Markets ,